Yinuo Medicine-B (02591): Hong Kong public offering oversubscribed by 5341.66 times.

Yinuo Pharmaceuticals-B (02591) announced the results of its allocation. The company issued a total of 36.5564 million shares globally, with 10% allocated for public sale in Hong Kong and 90% allocated for international sale. The final offering price was HK$18.68 per share, raising approximately HK$635 million in net proceeds from the global sale. Each board lot consisted of 200 shares. It is expected that the H shares will begin trading on the Hong Kong Stock Exchange on Friday, August 15, 2025, at 9:00 am. The public sale in Hong Kong was oversubscribed by 5341.66 times, while the international sale was oversubscribed by 10.67 times.